Pinal Patel is a Global Feasibility Lead – Oncology within Global Clinical Development Operations at Janssen: The Pharmaceutical Companies of Johnson & Johnson. In her current role, Pinal is responsible for strategy and implementation for country selection encompassing protocol planning and patient insights.
Prior to joining Janssen, she was an Engagement Strategy Lead at Bristol-Myers Squibb where she focused on building novel, fit for purpose patient and site centric strategies to drive enrollment for clinical trials in Oncology arena. Understanding the patient journey was at the center of it all in identifying risks and opportunities to achieve the end result. Pinal graduated from Connecticut College, USA with a B.A. in Psychology.